Intellectual Property

  • February 20, 2026

    7th Circ. Wary Of Tackling Jurisdiction In 2 'Schedule A' Suits

    Facing requests to address alleged jurisdictional shortcomings against e-commerce platforms in two mass counterfeiting cases Friday, a Seventh Circuit panel signaled that such discussion seems unwarranted in one vendor's fee appeal while resolving the issue separately for an e-commerce intermediary might be inappropriate given its unclear case record.

  • February 20, 2026

    Ex-Exec Must Arbitrate Claims In CoStar DQ-Embroiled Spat

    A California federal judge sent most of a former Matterport executive's harassment and retaliation suit to arbitration, amid a suit that has prompted CoStar's efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel in separate litigation.

  • February 20, 2026

    BioNTech Says Moderna's New COVID Vax Infringes Its IP

    BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal court.

  • February 20, 2026

    Squires Sinks 2 PTAB Challenges, Including 1 He Instituted

    U.S. Patent and Trademark Office Director John Squires has reversed his own decision and another made by the Patent Trial and Appeal Board to institute a pair of America Invents Act petitions, citing what he called the challengers' inconsistent claim construction.

  • February 20, 2026

    Fed. Circ. Backs PTAB Invalidation Of VideoLabs Patent Claims

    The Federal Circuit on Friday upheld a decision by the Patent Trial and Review Board that most of the challenged claims in a VideoLabs Collective patent for synchronizing data are invalid, finding VideoLabs had forfeited its argument by raising it for the first time before the circuit.

  • February 20, 2026

    Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP

    The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible. 

  • February 20, 2026

    Fed. Circ. OKs Micron's PTAB Loss In Netlist Patent Challenge

    The Federal Circuit on Friday upheld Patent Trial and Appeal Board decisions that Micron Technology Inc. failed to show that claims of a Netlist Inc. computer memory patent are invalid, part of a wide-ranging dispute that includes a nine-figure verdict against Micron on other patents.

  • February 20, 2026

    Dinsmore Adds IP Partner In Texas From Fish & Richardson

    Dinsmore & Shohl LLP has hired a Fish & Richardson PC intellectual property lawyer who has advanced degrees in mechanical and aerospace engineering and practiced at his previous firm for more than 20 years, the firm announced Wednesday.

  • February 20, 2026

    2nd Circ. Backs $286K For Childish Gambino's Attys

    The Second Circuit has approved a $286,000 attorney fee award granted to lawyers representing rapper Childish Gambino and his record label in a case from another rapper who alleged part of the hit song "This Is America" was lifted from one of his tracks.

  • February 20, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.

  • February 19, 2026

    Ex-Google Engineers Took Trade Secrets To Iran, DOJ Says

    Three Silicon Valley engineers exploited their employment at Google and other major tech companies in order to steal trade secrets and send the confidential information to personal devices that they then accessed in Iran, the U.S. Department of Justice said Thursday.

  • February 19, 2026

    Lab Seeks Rare Essential Patent Injunction In Wi-Fi Case

    Citing recent encouragement from federal agencies, a Korean research lab is seeking a rare permanent injunction in a case involving standard essential patents, after a unit of Taiwan's Asus stipulated that its routers infringe the lab's essential Wi-Fi patents.

  • February 19, 2026

    Trump's Push For Airport TMs Unprecedented, Experts Say

    President Donald Trump's effort to register trademarks for airports that could someday bear his name represents a striking break from how past presidents have gotten their names placed on landmarks, intellectual property attorneys say.

  • February 19, 2026

    Justices Urged To Bar Passive Infringement For Skinny Labels

    The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme Court in a case over so-called skinny labels.

  • February 19, 2026

    Producers Drop Karol G 'Gatúbela' Suit, Issue Apology

    Two music producers who accused star Colombian singer Karol G and Universal Music Group of lifting the beat from their track for her hit song "Gatúbela" told a Florida federal court Wednesday that they are dropping their claims and will publicly apologize.

  • February 19, 2026

    Funder Longford Wins Patent Litigation Settlement Dispute

    Litigation funder Longford Capital has prevailed in arbitration relating to a dispute with Arigna Technology Ltd. over a settlement that ended certain patent litigation, according to documents filed in Delaware federal court.

  • February 19, 2026

    Judge Affirms Literal Infringement In Ravgen's $57M Jury Win

    A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.

  • February 19, 2026

    Shkreli Again Tries To Add Wu-Tang Members To Album Fight

    "Pharma Bro" Martin Shkreli filed a third-party complaint against two members of hip-hop group Wu-Tang Clan, seeking once again to bring them into litigation brought by a cryptocurrency community that claims Shkreli improperly retained copies of a Wu-Tang album the community had bought the rights to.

  • February 19, 2026

    Flavored Air Co. Seeks Ch. 15 Nod In Nevada After Settlement

    A Canadian flavored air device company is asking a Nevada bankruptcy judge to recognize the Canadian insolvency proceedings it began earlier this month after falling behind in payments from the settlement of a U.S. trademark infringement suit.

  • February 19, 2026

    She Has A Point: Dechert's Kassie Helm

    Kassie Helm, co-chair of Dechert LLP's global intellectual property group and head of its IP litigation group, is "unquestionably one of the leading lights of her generation," according to Morrison Foerster LLP partner Daralyn Durie, who praised Helm for her work as opposing counsel in a new series celebrating women litigators.

  • February 19, 2026

    Squires Accepts 8 PTAB Cases, Walks Back 7 Merits Referrals

    A bulk summary order from U.S. Patent and Trademark Office Director John Squires granted eight petitions for America Invents Act patent challenges while denying 14 others, including seven that he had previously accepted for merits-based review.

  • February 19, 2026

    Fed. Circ. OKs Decision Clearing Sony In $500M Patent Case

    The Federal Circuit on Thursday upheld a decision that Sony's PlayStation controllers do not infringe a computer input device patent, in a case where Sony said patent owner Genuine Enabling Technology was seeking nearly $500 million in damages.

  • February 19, 2026

    Fed. Circ. Won't Revive Corcept's Drug Patent Feud

    The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.

  • February 19, 2026

    Foley & Lardner Brings On 4 IP, Corporate Attys In Calif.

    Foley & Lardner LLP is expanding its California team, announcing Thursday it is adding four partners with technology-related experience — two in San Diego, one in San Francisco and one in Silicon Valley.

  • February 19, 2026

    Tech Co. Seeks Morgan Lewis DQ From Smart Glasses Case

    A Hong Kong-based tech company has asked a Massachusetts federal judge to kick Morgan Lewis & Bockius LLP off of a case in which it's accusing Meta Platforms and Oakley Inc. of infringing patents with their smart glasses technology.

Expert Analysis

  • Demystifying Generative AI For The Modern Juror

    Author Photo

    In cases alleging that the training of artificial intelligence tools violated copyright laws, successful outcomes may hinge in part on the litigator's ability to clearly present AI concepts through a persuasive narrative that connects with ordinary jurors, say Liz Babbitt at IMS Legal Strategies and Devon Madon at GlobalLogic.

  • Series

    Power To The Paralegals: How And Why Training Must Evolve

    Author Photo

    Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.

  • Series

    Playing Softball Makes Me A Better Lawyer

    Author Photo

    My time on the softball field has taught me lessons that also apply to success in legal work — on effective preparation, flexibility, communication and teamwork, says Sarah Abrams at Baleen Specialty.

  • And Now A Word From The Panel: Choosing MDL Venues

    Author Photo

    One of the most interesting yet least predictable facets of the Judicial Panel on Multidistrict Litigation's practice is venue — namely where the panel decides to place a new MDL proceeding — and its choices reflect the tension between neutrality and case-specific factors, says Alan Rothman at Sidley.

  • Fed. Circ. In August: A Framework For AIA Derivation Disputes

    Author Photo

    In Global Health Solutions v. Selner, the Federal Circuit established how to assess derivation challenges under the America Invents Act's first-to-file system, making it easier for petitioners to determine a challenge's odds of success, say attorneys at Knobbe Martens.

  • USPTO's Track One A Reliable Patent Pathway Amid Backlog

    Author Photo

    As the U.S. Patent and Trademark Office faces a backlog of unexamined utility, plant and reissue patent applications, patent applicants should consider utilizing the USPTO's Track One Program, which not only expedites the process but also increases the likelihood of working with more senior examiners, says Ryan Schermerhorn at Marshall Gerstein.

  • How New Rule On Illustrative Aids Is Faring In Federal Courts

    Author Photo

    In the 10 months since new standards were codified for illustrative aids in federal trials, courts have already begun to clarify the rule's application in different contexts and the rule's boundaries, say attorneys at Bernstein Litowitz.

  • What Novel NIL Suit Reveals About College Sports Landscape

    Author Photo

    A first-of-its-kind name, image and likeness lawsuit — recently filed in Wisconsin state court by the University of Wisconsin-Madison against the University of Miami — highlights new challenges and risks following the NCAA’s landmark agreement to allow schools to make NIL deals and share revenue with student-athletes, say attorneys at O'Melveny.

  • Series

    Law School's Missed Lessons: Mastering Time Management

    Author Photo

    Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.

  • How Hyperlinks Are Changing E-Discovery Responsibilities

    Author Photo

    A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.

  • Beaming Up Lessons From William Shatner's Failed Patent Bid

    Author Photo

    In a tale that boldly goes where few celebrity inventors have gone before, William Shatner's unsuccessful attempt to patent a smartphone file organization system offers insights about potential pitfalls to avoid in patent applications, say attorneys at King & Spalding.

  • The Pros And Cons Of Levying Value-Based Fees On Patents

    Author Photo

    The potential for a recurring, value-based maintenance fee on patents, while offering some benefits, raises several complications, including that it would likely exceed the U.S. Patent and Trademark Office's statutory authority and reduce research and development activities in the U.S., says Sandip Patel at Marshall Gerstein.

  • Strategies To Get The Most Out Of A Mock Jury Exercise

    Author Photo

    A Florida federal jury’s recent $329 million verdict against Tesla over a fatal crash demonstrates how jurors’ perceptions of nuanced facts can make or break a case, and why attorneys must maximize the potential of their mock jury exercises to pinpoint the best trial strategy, says Jennifer Catero at Snell & Wilmer.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Between The Lines Of EPO's Adoption Of Color Drawings

    Author Photo

    The European Patent Office's decision to accept patent drawings in color starting in October may enhance clarity in technical disclosures and streamline the examination process, and could also enable new patent filing strategies for international applicants, say attorneys at Miller Canfield.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.